LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

Начало・Списък с акции・Celsion Corp

Celsion Corp

Затворен

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

Максимум

Ключови измерители
By Trading Economics
Служители	25

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+771.08% upside

Пазарни показатели
By TradingEconomics
Пазарна капитализация	938K
Предишно отваряне	0
Предишно затваряне	0

Celsion Corp Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

20.03.2026 г., 17:19 ч. UTC

Значими събития в новините

Chubb to Assume Risk, Issue Policies for $20 Billion Strait of Hormuz Insurance Facility

20.03.2026 г., 16:56 ч. UTC

Значими събития в новините

Week Ahead for FX, Bonds: PMI Data to Show Middle East War's Impact on Sentiment

20.03.2026 г., 16:56 ч. UTC

Значими събития в новините

Week Ahead for FX, Bonds: PMI Data to Show Middle -2-

20.03.2026 г., 16:45 ч. UTC

Значими събития в новините

The Week in Oil: U.S. Seeks to Ease Concerns Over War But Supply Risks Mount

20.03.2026 г., 16:22 ч. UTC

Значими събития в новините

NYMEX Overview: Petroleum Futures Rise, Leaving Most Contracts on Track for Solid Weekly Gains -- OPIS

21.03.2026 г., 16:00 ч. UTC

Значими събития в новините

Empires Have Battled Over the Strait of Hormuz for Centuries -- WSJ

21.03.2026 г., 08:20 ч. UTC

Пазарно говорене

Значими събития в новините

Basic Materials Roundup: Market Talk

21.03.2026 г., 00:05 ч. UTC

Придобивния, сливания и поглъщания

Oil, Long And Short -- Barrons.com

20.03.2026 г., 20:50 ч. UTC

Пазарно говорене

Значими събития в новините

Basic Materials Roundup: Market Talk

20.03.2026 г., 20:50 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Health Care Roundup: Market Talk

20.03.2026 г., 19:55 ч. UTC

Пазарно говорене

Значими събития в новините

Brent Crude Closes Out Volatile Week Higher -- Market Talk

20.03.2026 г., 19:28 ч. UTC

Пазарно говорене

Значими събития в новините

Natural Gas Falls as Traders Sell Ahead of the Weekend -- Market Talk

20.03.2026 г., 19:28 ч. UTC

Придобивния, сливания и поглъщания

Ecolab Buys CoolIT Systems for $4.75 Billion. It's All About AI for the Struggling Stock. -- Barrons.com

20.03.2026 г., 18:39 ч. UTC

Пазарно говорене

Gold Settles With Largest Weekly Dollar Decline on Record -- Market Talk

20.03.2026 г., 18:31 ч. UTC

Придобивния, сливания и поглъщания

Honeywell Announces Pricing of Debt Tender Offers >HON

20.03.2026 г., 18:19 ч. UTC

Придобивния, сливания и поглъщания

Why Mayo and Soap No Longer Mix for Unilever -- Update

20.03.2026 г., 18:15 ч. UTC

Пазарно говорене

iMarkets May Be Wrong in Pricing for Canadian Rate Increases -- Market Talk

20.03.2026 г., 17:57 ч. UTC

Пазарно говорене

U.S. Oil Rig Count Inches Up -- Market Talk

20.03.2026 г., 17:04 ч. UTC

Значими събития в новините

Chubb to Assume Risk, Issue Policies for $20B Strait of Hormuz Insurance Facility

20.03.2026 г., 16:20 ч. UTC

Пазарно говорене

Значими събития в новините

Basic Materials Roundup: Market Talk

20.03.2026 г., 16:20 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Health Care Roundup: Market Talk

20.03.2026 г., 15:40 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Unilever, McCormick Deal Makes Strategic Sense, But Risk Remains -- Market Talk

20.03.2026 г., 15:30 ч. UTC

Печалби

Gemini Space Station's Earnings 'Better Than Feared.' Can They Save the Stock? -- Barrons.com

20.03.2026 г., 15:26 ч. UTC

Пазарно говорене

Печалби

Значими събития в новините

Lands' End: War Impacts Weighing on Some European Consumers -- Market Talk

20.03.2026 г., 15:26 ч. UTC

Придобивния, сливания и поглъщания

Why Mayo and Soap No Longer Mix for Unilever -- WSJ

20.03.2026 г., 15:25 ч. UTC

Пазарно говорене

Gilt Selloff Shows Vulnerability of U.K.'s Economy -- Market Talk

20.03.2026 г., 15:19 ч. UTC

Пазарно говорене

Значими събития в новините

UBS Raises Oil Price Forecast as Middle East Conflict Escalates -- Market Talk

20.03.2026 г., 14:58 ч. UTC

Значими събития в новините

Chevron Jumps Into Top 20 Most Valuable U.S. Companies. The Iran War's Other Big Stock Movers. -- Barrons.com

20.03.2026 г., 14:55 ч. UTC

Пазарно говорене

Значими събития в новините

Gold Lower as Speculative Pullback Extends -- Market Talk

20.03.2026 г., 14:54 ч. UTC

Придобивния, сливания и поглъщания

Ecolab Buys CoolIT Systems for $4.75 Billion. It's All About AI for the Struggling Stock. -- Barrons.com

Сравнение с други в отрасъла

Ценова промяна

Celsion Corp Прогноза

Ценова цел

By TipRanks

771.08% нагоре

12-месечна прогноза

Среден 25 USD 771.08%

Висок 25 USD

Нисък 25 USD

Според 1 анализатори от Wall Street, предложили 12-месечна ценова цел за Celsion Corp през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

1 ratings

Купи

Задържане

Продай

Според 1 анализатори, дали борсови рейтинги на Celsion Corp през последните 3 месеца.

Финанси

Относно Celsion Corp

Imunon, Inc., a clinical-stage biotechnology company, engages in the development of immunotherapies and vaccines to treat cancer and infectious diseases. The company's lead clinical program IMNN-001, a DNA-based immunotherapy for the localized treatment of ovarian cancer that is in Phase II clinical development. Its preclinical stage products include IMNN-101, a COVID-19 booster vaccine; IMNN-102 for the treatment of Lassa virus; and IMNN-201, a Trp2 tumor associated antigen cancer vaccine in melanoma. In addition, the company develops non-viral DNA technology across four modalities, such as TheraPlas for the coding of proteins and cytokines in the treatment of solid tumors; PlaCCine for the coding of viral antigens that can elicit a strong immunological response; FixPlas for the application of Imunon's DNA technology to produce universal cancer vaccines; and IndiPlas, which is in the discovery phase for the development of personalized cancer vaccines or neoepitope cancer vaccines. Imunon, Inc. was formerly known as Celsion Corporation and changed its name to Imunon, Inc. in September 2022. The company was founded in 1982 and is headquartered in Lawrenceville, New Jersey.